On February 27, 2026, iBio, Inc. entered into an agreement to sell up to $100 million in common stock through Jefferies LLC, replacing a previous agreement that was terminated. The prior agreement allowed for the sale of up to $7.35 million in stock, ending on February 23, 2026.